ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $36,000 | +140.0% | 209 | +74.2% | 0.00% | – |
| Q2 2021 | $15,000 | -6.2% | 120 | 0.0% | 0.00% | – |
| Q1 2021 | $16,000 | +14.3% | 120 | +6.2% | 0.00% | – |
| Q4 2020 | $14,000 | -63.2% | 113 | -66.6% | 0.00% | – |
| Q3 2020 | $38,000 | +40.7% | 338 | +12.7% | 0.00% | -100.0% |
| Q2 2020 | $27,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q1 2020 | $27,000 | +68.8% | 300 | 0.0% | 0.00% | – |
| Q4 2019 | $16,000 | +23.1% | 300 | -8.8% | 0.00% | – |
| Q3 2019 | $13,000 | -7.1% | 329 | 0.0% | 0.00% | – |
| Q2 2019 | $14,000 | -6.7% | 329 | 0.0% | 0.00% | – |
| Q1 2019 | $15,000 | +36.4% | 329 | +31.6% | 0.00% | – |
| Q4 2018 | $11,000 | -21.4% | 250 | 0.0% | 0.00% | – |
| Q3 2018 | $14,000 | +16.7% | 250 | 0.0% | 0.00% | – |
| Q2 2018 | $12,000 | +20.0% | 250 | 0.0% | 0.00% | – |
| Q1 2018 | $10,000 | – | 250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |